Merck Vaccines Performance Data Summary 2005-2008

	2008	2007	2006	2005
Number of countries where Merck has committed to no-profit prices for ROTATEQ and GARDASIL	72	72	N/A	N/A
Number of low and middle income countries using Merck's vaccines in their public sectors	16	11	N/R	N/R
Number of vaccines approved, registered in number of countries	11 vaccines in 114 countries	11 vaccines in more than 100 countries	N/R	N/R
Number of doses sold worldwide of ROTATEQ, GARDASIL and MMRII	55.9M	46.5M	N/R	N/R
In high human development index (HDI) countries	52.6M	44M	N/R	N/R
In medium HDI countries	3.3M	1.6M	N/R	N/R
In low HDI countries	43,000	0	N/R	N/R
In GAVI countries*	603,000	504,000	N/R	N/R
Number of new country registrations of GARDASIL and ROTATEQ globally† (and cumulative to date)	18 (196)	72 (178)	105 (106)	1 (1)
In high HDI countries	6 (119)	31 (113)	81 (82)	1 (1)
In medium HDI countries	11 (51)	28 (40)	12 (12)	0 (0)
In low HDI countries	1 (17)	11 (16)	5 (5)	0 (0)
In GAVI countries*	8 (38)	21 (30)	9 (9)	0 (0)
Partnership data:
Merck investment in MVN-A ($US)	800,000	1M	400,000	400,000
Number of health care professionals trained through MVN-A	142	97	103	89
ROTATEQ Access Program (Nicaragua) : total doses of vaccine delivered as 1st, 2nd or 3rd dose (as of 12/31/2008)	329,560	291,797	20,325	N/A
Total doses of ROTATEQ delivered as 3rd dose (fully vaccinated child) (as of 12/31/2008)	106,700	87,611	0	N/A
Vaccine coverage (% receiving 3rd dose of ROTATEQ) among Nicaraguan infants. (as of 12/31/2008)	81%	80%	0	N/A

* GAVI list includes 72 countries that are eligible for funding; this includes countries that are classified as low HDI as well as some countries that are classified as medium HDI. Fifteen UN member countries are not included in the HDI due to lack of data.
† Prior year data have been adjusted due to a change in methodology.

 

The content on this page was last modified on September 15, 2009.

Merck & Co., Inc., Whitehouse Station, NJ, USA, and Schering-Plough Corporation, Kenilworth, NJ, USA, are now one company. We have combined our global operations under the name Merck & Co., Inc. We are working to update our corporate responsibility Web site to reflect our new, combined, global organization.